# Kam Lawrence

> Institutional holdings reported to the SEC as of Q4 2019 on Form 13F. CIK 1802765. Source: https://holderbook.com/funds/1802765-kam-lawrence/

- Reported value: $97.4M
- Positions: 7
- Weight of the ten largest: 100.0%
- Filed: 2020-02-13

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| ADVERUM BIOTECHNOLOGIES INC | [ADVM](https://holderbook.com/stocks/ADVM/) | $46.6M | 4,043,212 | 47.8% | 1 |
| REGENXBIO INC | [RGNX](https://holderbook.com/stocks/RGNX/) | $19.1M | 465,664 | 19.6% | 1 |
| SAREPTA THERAPEUTICS INC | [SRPT](https://holderbook.com/stocks/SRPT/) | $14.5M | 112,689 | 14.9% | 1 |
| GENWORTH FINL INC | [GNW](https://holderbook.com/stocks/GNW/) | $9.2M | 2,097,335 | 9.5% | 1 |
| FENNEC PHARMACEUTICALS INC | [FENC](https://holderbook.com/stocks/FENC/) | $5.4M | 834,689 | 5.6% | 1 |
| THIRD PT REINS LTD | [TPRE](https://holderbook.com/stocks/TPRE/) | $2.4M | 227,185 | 2.5% | 1 |
| TRONOX HOLDINGS PLC | [TROX](https://holderbook.com/stocks/TROX/) | $149.0K | 13,055 | 0.2% | 1 |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q4 2019 | $97.4M | 7 |